Skip survey header

Prenatal Iodine Supplementation and Early Childhood Neurodevelopment (PoppiE) Research Study

Join Now - Study Measuring Iodine Among Pregnant Mothers  


Pregnant women have the greatest need for iodine; thus, they are advised to take iodine supplements on top of their iodine from their diet. This research study aims to determine the most favorable amount of iodine supplementation for pregnant women who already consume enough iodine from their food intake. Interested participants must be less than 13 weeks into their pregnancy.

Why Participate?
  • Participants will receive prenatal supplements for the whole of their pregnancy at no charge.
  • Participants will know their iodine status by completing an Iodine intake Food Frequency Questionnaire (iFFQ).
  • Participants receive an in depth developmental assessment of their child at 2 years of age and will receive an assessment report as part of this study.
  • Participants will be reimbursed for attendance at the 24-month developmental assessments with their child.
Who Can Participate?
  • Pregnant women who are less than 13 weeks into their pregnancy.
  • Able to attend one study visit at a local research centre.
  • Able to answer brief SMS surveys, phone calls and attend a study visit at the research site when their baby is 24 months of age, as well as comply with all the necessary study requirements.
  • Must be willing to take an online 10- minute Food Frequency Questionnaire to determine iodine intake.
Study Details and Locations

Research Centre 1: South Australian Health and Medical Research Institute (SAHMRI) in conjunction with the Women's and Children's Hospital and Flinders Medical Centre Locations:
  • SAMHRI: North Terrace, Adelaide SA 5000, Australia
  • Women’s and Children’s Hospital: 72 King William Rd, North Adelaide SA 5006 Australia
  • Flinders Medical Centre: Bedford Park SA 5042, Australia

Research Centre 2: The Mater Mothers Hospital
Location: Raymond Terrace, South Brisbane QLD 4101, Australia

Research Centre 3: The Royal Women's Hospital
Location: 20 Flemington Rd, Parkville VIC 3052, Australia

Research Centre 4: Royal North Shore Hospital
Location: Reserve Rd, St Leonards NSW 2065, Australia

Lead Researcher: Dr. Karen Best
Ethics Committee: This study has been reviewed and approved by Women’s and Children’s Health Network (WCHN) Ethics Committee

Consent to Continue

After completing this brief questionnaire, more detailed information will be provided to you before you decide whether or not to take part in the research, and you will have the opportunity to speak with and ask questions to a study coordinator. You can stop this discussion at any time.
Please note that by completing this questionnaire, you consent to Trialfacts collecting your answers to the questions, including your contact information. All information you provide in this questionnaire will be held in strict confidence, and shared only with the research center conducting the study. Trialfacts will delete your information from our records upon your request. While completing the questionnaire you will have the option to join our mailing list to be contacted via email about future clinical trials for which you may be eligible. Trialfacts may also reach out to you to gather feedback around your experience with us.You will not be contacted if you choose not to sign up to our mailing list.

For your reference, please find a link to the Trialfacts Privacy Policy.
Please note:
Due to the current situation with COVID-19 pandemic, the study team would like to point out the following:
  • This study has been designed so that there are no face to face visits until your baby is 24 months of age.
  • The research site’s waiting area is spacious enough that participants will not be within close proximity to each other.
  • Hand sanitisers are available at the research site.
  • The research staff adheres to strict hygienic practices as well as other safety measures to prevent the spread of COVID-19. 
  • Any staff suspected to have COVID-19, or has come into contact with someone who has COVID-19, will automatically undergo a voluntary quarantine for 14 days.
  • Interested participants will not be left waiting for a long period of time and will be quickly attended to. 
  • The research site/institution is taking all precautionary measures to ensure the safety of the study participants.

Are you willing to continue? *This question is required.